Literature DB >> 2559306

Detection of human papillomavirus deoxyribonucleic acid in the female genital tract.

J Czeglédy1, L Gergely, Z Hernádi, R Póka.   

Abstract

A total of 336 biopsies, scrapes and exfoliated cells from the cervix and from the lower genital tract were screened for human papilloma (HP) viral sequences of types 6, 11, 16 and 18 by Southern blot, dot blot and filter in situ (FISH) hybridizations with cloned 32P-radiolabeled HPV DNA probes. The specimens included cervical intraepithelial neoplasias (CIN I-III), carcinoma in situ and invasive carcinoma of the cervix and vagina, adenocarcinomas, vulvar and vaginal condylomata acuminata and healthy epithelial samples. The oncogenic HPV 16 was found in 46% of the cervical carcinomas. Most of the type 16 occurrences (75%) represented the third stage of inoperable cases. Similarly, HPV 18 was also most frequently present in this stage as well as in carcinoma in situ and in CIN III (25%, 18%). At the same time, in condylomata acuminata, types 6 and 11 were detectable in 88.7% of cares. In all, 13.5% of the normal samples harboured HPV DNA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2559306     DOI: 10.1007/BF00197449

Source DB:  PubMed          Journal:  Med Microbiol Immunol        ISSN: 0300-8584            Impact factor:   3.402


  22 in total

1.  Human papillomavirus DNA in normal, metaplastic, preneoplastic and neoplastic epithelia of the cervix uteri.

Authors:  P G Fuchs; F Girardi; H Pfister
Journal:  Int J Cancer       Date:  1988-01-15       Impact factor: 7.396

2.  Papillomavirus DNA in cervical carcinoma specimens from central China.

Authors:  X Xiao; M Cao; T R Miller; Z Y Cao; T S Yen
Journal:  Lancet       Date:  1988-10-15       Impact factor: 79.321

3.  Prevalence of human papillomavirus type 16 DNA in cervical carcinoma samples in East Anglia.

Authors:  S M Scholl; E M Pillers; R E Robinson; P J Farrell
Journal:  Int J Cancer       Date:  1985-02-15       Impact factor: 7.396

4.  Genome organization of herpesvirus aotus type 2.

Authors:  P G Fuchs; R Rüger; H Pfister; B Fleckenstein
Journal:  J Virol       Date:  1985-01       Impact factor: 5.103

5.  Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia.

Authors:  L Dillner; Z Bekassy; N Jonsson; J Moreno-Lopez; J Blomberg
Journal:  Int J Cancer       Date:  1989-01-15       Impact factor: 7.396

6.  Optimization of human papillomavirus genotype detection in cervical scrapes by a modified filter in situ hybridization test.

Authors:  W J Melchers; P Herbrink; J M Walboomers; C J Meijer; H vd Drift; J Lindeman; W G Quint
Journal:  J Clin Microbiol       Date:  1989-01       Impact factor: 5.948

7.  Detection of human papillomavirus deoxyribonucleic acid in exfoliated cervicovaginal cells as a predictor of cervical neoplasia in a high-risk population.

Authors:  D B Ritter; A S Kadish; S H Vermund; S L Romney; D Villari; R D Burk
Journal:  Am J Obstet Gynecol       Date:  1988-12       Impact factor: 8.661

8.  Human papillomavirus type 16 and early cervical neoplasia.

Authors:  C P Crum; H Ikenberg; R M Richart; L Gissman
Journal:  N Engl J Med       Date:  1984-04-05       Impact factor: 91.245

9.  Human papillomavirus infections in women with and without abnormal cervical cytology.

Authors:  E M de Villiers; D Wagner; A Schneider; H Wesch; H Miklaw; J Wahrendorf; U Papendick; H zur Hausen
Journal:  Lancet       Date:  1987-09-26       Impact factor: 79.321

10.  Condylomatous lesions of the cervix and vagina. I. Cytologic patterns.

Authors:  A Meisels; R Fortin
Journal:  Acta Cytol       Date:  1976 Nov-Dec       Impact factor: 2.319

View more
  5 in total

1.  Detection of transforming gene regions of human papillomavirus type 16 in cervical dysplasias by the polymerase chain reaction.

Authors:  J Czeglédy; M Evander; L Veres; L Gergely; G Wadell
Journal:  Med Microbiol Immunol       Date:  1991       Impact factor: 3.402

2.  Human papillomavirus type 18 E6 and E7 antibodies in human sera: increased anti-E7 prevalence in cervical cancer patients.

Authors:  C Bleul; M Müller; R Frank; H Gausepohl; U Koldovsky; H N Mgaya; J Luande; M Pawlita; J ter Meulen; R Viscidi
Journal:  J Clin Microbiol       Date:  1991-08       Impact factor: 5.948

3.  Analysis of transforming gene regions of human papillomavirus type 16 in normal cervical smears.

Authors:  J Czeglédy; I Batár; M Evander; L Gergely; G Wadell
Journal:  Arch Gynecol Obstet       Date:  1991       Impact factor: 2.344

Review 4.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

5.  Detection of human papillomavirus DNA in genital lesions by using a modified commercially available in situ hybridization assay.

Authors:  M P Meyer; C A Markiw; R R Matuscak; A Saker; K McIntyre-Seltman; A J Amortegui
Journal:  J Clin Microbiol       Date:  1991-07       Impact factor: 5.948

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.